Literature DB >> 16995592

Pseudohypoparathyroidism type 1a with congenital hypothyroidism.

Jordan E Pinsker1, William Rogers, Scott McLean, Frederick V Schaefer, Cydney Fenton.   

Abstract

Pseudohypoparathyroidism type la (PHP-1a) is an uncommon disorder that results from an inactivating mutation in the GNAS gene. It can present with resistance to several hormones, in addition to parathyroid hormone (PTH). Patients may have the classic Albright's hereditary osteodystrophy (AHO) phenotype and can develop resistance to thyroid stimulating hormone (TSH), gonadotropins, growth hormone releasing hormone (GHRH), and other hormones that rely on the Gsalpha protein to regulate signal transmission at their receptors. We report two siblings with PHP-1a and congenital hypothyroidism. The patients were found to have a heterozygous mutation at nucleotide 305 in exon 4 (c305C-->A) of the GNAS gene, which has not been previously linked to congenital hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995592     DOI: 10.1515/jpem.2006.19.8.1049

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  13 in total

Review 1.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 2.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

3.  A novel mutation causing pseudohypoparathyroidism 1A with congenital hypothyroidism and osteoma cutis.

Authors:  Tamar Lubell; Maria Garzon; Kwame Anyane Yeboa; Bina Shah
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-06

4.  Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.

Authors:  Xiao-Dan Long; Jing Xiong; Zhao-Hui Mo; Chang-Sheng Dong; Ping Jin
Journal:  BMC Med Genet       Date:  2018-07-30       Impact factor: 2.103

5.  Pseudohypoparathyroidism: application of the Italian common healthcare-pathway for a homogeneous clinical approach and a shared follow up.

Authors:  Daniele Tessaris; Elisa Bonino; Giovanna Weber; Malgorzata Wasniewska; Domenico Corica; Marco Pitea; Giuseppe Scirè; Manuela Caruso-Nicoletti; Danilo Fintini; Luisa de Sanctis
Journal:  Ital J Pediatr       Date:  2021-03-04       Impact factor: 2.638

Review 6.  Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?

Authors:  Francesca Marta Elli; Giovanna Mantovani
Journal:  Endocrine       Date:  2020-11-11       Impact factor: 3.633

7.  Endocrinology and the arts at the feet of the dancing Lord: Parathyroid hormone resistance in an Indian icon.

Authors:  Krishna G Seshadri
Journal:  Indian J Endocrinol Metab       Date:  2014-03

8.  Iodide transport: implications for health and disease.

Authors:  Liuska Pesce; Peter Kopp
Journal:  Int J Pediatr Endocrinol       Date:  2014-05-30

9.  (Epi)genotype-Phenotype Analysis in 69 Japanese Patients With Pseudohypoparathyroidism Type I.

Authors:  Shinichiro Sano; Akie Nakamura; Keiko Matsubara; Keisuke Nagasaki; Maki Fukami; Masayo Kagami; Tsutomu Ogata
Journal:  J Endocr Soc       Date:  2017-11-21

Review 10.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.